KWD+® (Kiwi Fruit Extract for Protein Digestion — Pharmactive)

Actinidia chinensis / Actinidia deliciosa
Evidence Level
Moderate
3 Clinical Trials
7 Documented Benefits
3/5 Evidence Score

KWD+® is Pharmactive Biotech Products' high-performance kiwi fruit (Actinidia deliciosa) extract for protein digestion and gut motility support. Sourced from traditionally cultured New Zealand kiwi and manufactured in Spain. Standardized to ≥0.15% actinidin (a proteolytic enzyme that breaks down proteins) and ≥0.1% Aktinnamics® (a proprietary antioxidant phenolic complex). Proprietary technology concentrates the proteolytic enzymes ~5-fold compared to fresh kiwi. Positioned for three demographics: sports enthusiasts, the elderly, and vegetarians/vegans needing better protein utilization. Clinical doses: 300 mg/day for maintenance, 600 mg before heavy meals.

Studied Dose 300 mg/day for maintenance; 600 mg before a heavy meal.
Active Compound Kiwi (Actinidia deliciosa) extract standardized to ≥0.15% actinidin (proteolytic enzyme) and ≥0.1% Aktinnamics® (phenolic antioxidant complex).

Benefits

Protein digestion enhancement via actinidin

Actinidin is a cysteine protease enzyme that breaks down proteins in the stomach and small intestine, converting them into more digestible peptides. KWD+ contains ~5× the actinidin concentration of fresh kiwi. Animal model and bench studies support actinidin's ability to improve digestion of hard-to-digest proteins including gluten, soy protein, and beef muscle.

Vegetarian and vegan protein utilization

Plant proteins typically have lower bioavailability than animal proteins. KWD+ helps vegetarians and vegans increase the biological value of vegetable proteins — getting more nutritional benefit from the same protein intake. Practical relevance for the growing plant-based diet population concerned about protein adequacy.

Sports nutrition protein efficiency

For sport professionals and athletes, KWD+ supports better harnessing of proteins — potentially enhancing the amino acid availability needed for muscle protein synthesis and recovery. Doping-free certification makes it suitable for competitive athletes subject to WADA-style testing protocols.

Elderly digestion support

Protein digestion efficiency declines with age due to reduced gastric acid secretion (hypochlorhydria) and lower endogenous proteolytic enzyme production. KWD+ provides supplemental actinidin enzyme activity to support the elderly population's protein utilization — relevant for preserving lean muscle mass during aging.

Gentle gastrointestinal motility

Kiwi fruit is well-established for supporting gut motility — kiwi consumption is one of the few dietary interventions with controlled trial evidence for constipation relief. KWD+ provides concentrated kiwi bioactives in a small capsule, supporting motility without the calorie and FODMAP load of whole kiwi fruit.

Reduced digestive discomfort

KWD+ helps prevent discomforts during digestion such as bloating, fullness, and pain. The dual mechanism — actinidin breaking down proteins more efficiently plus Aktinnamics® reducing inflammatory signaling — addresses both mechanical and inflammatory components of post-meal digestive discomfort.

TNF-α anti-inflammatory activity

The Aktinnamics® phenolic complex has documented inhibitory action on pro-inflammatory mediators including TNF-α (tumor necrosis factor-alpha). Reducing pro-inflammatory signaling in the gut supports overall digestive comfort beyond simple enzymatic protein breakdown. Mechanism documented in vitro and in vivo preclinical research.

Mechanism of action

1

Actinidin cysteine protease activity

Actinidin is a cysteine protease enzyme — structurally and functionally similar to bromelain (from pineapple) and papain (from papaya). It catalyzes peptide bond hydrolysis in proteins, breaking them down into smaller peptides that are more easily absorbed by the small intestine. Active across a broad pH range, allowing function in both stomach and intestine.

2

5-fold actinidin concentration

Pharmactive's proprietary extraction technology concentrates proteolytic enzymes ~5× the level found in fresh kiwi fruit. This concentration matters because the protein-digesting effect requires meaningful enzyme presence at the time of protein consumption — achievable practically only through extract concentration rather than eating multiple whole kiwi fruits with each meal.

3

Aktinnamics® phenolic anti-inflammatory activity

Aktinnamics® is the proprietary name for KWD+'s characteristic phenolic compound complex — antioxidants chiefly responsible for the anti-inflammatory effects. Documented in vitro and in vivo as inhibiting pro-inflammatory mediators including TNF-α. Supports gut function beyond pure protein digestion effects.

4

Gut motility support

Kiwi fruit's effects on gut motility are well-documented from whole-fruit clinical trials (notably for constipation in functional GI disorders). The exact molecular mechanism is multi-factorial — including fiber content, actinidin's effects on intestinal contents, and possibly serotonergic effects on enteric nervous system. KWD+ preserves these benefits in concentrated form.

Clinical trials

1
KWD+ Actinidin Protein Digestion — Preclinical Foundation

Animal models and bench (in vitro) studies examining actinidin's ability to improve digestion of various proteins in the stomach and small intestine. Test proteins included challenging-to-digest classes: gluten, soy protein, and beef muscle. Foundation for KWD+'s commercial positioning across sports, vegan, and elderly populations.

Not applicable — animal model and in vitro bench studies.

Actinidin from KWD+ effectively breaks down challenging proteins (gluten, soy, beef muscle) into more digestible peptide fractions in stomach and small intestine conditions. 5-fold enzyme concentration vs fresh kiwi maintains physiologically relevant activity at supplemental doses. Supports the three target population use cases.

2
Kiwi Fruit for Gut Motility — Class Evidence

Multiple controlled trials of whole kiwi fruit consumption (typically 2 green kiwifruit/day) for constipation and functional gastrointestinal disorders. Published in journals including Alimentary Pharmacology & Therapeutics. Provides class-evidence foundation for KWD+'s motility positioning, since the concentrated extract preserves the same bioactive classes.

Adults with constipation and functional GI disorders across multiple trials.

Whole kiwi fruit consumption (2 green kiwifruit/day) improved bowel movement frequency, stool consistency, and reduced straining vs control in controlled trials. Effect emerged within days to weeks of consistent use. KWD+ preserves the kiwi bioactive profile in concentrated form, supporting similar motility effects at smaller volumes than eating whole kiwi fruits daily.

3
Aktinnamics® Anti-Inflammatory Activity — Mechanism Studies

In vitro and in vivo studies characterizing the Aktinnamics® phenolic complex's anti-inflammatory mechanism. Tested effects on pro-inflammatory cytokines including TNF-α and broader inflammatory signaling pathways. Provides mechanistic basis for the gut comfort and motility effects beyond pure protein digestion.

Not applicable — in vitro and in vivo mechanism studies.

Aktinnamics® inhibited pro-inflammatory mediators including TNF-α in vitro. In vivo studies confirmed anti-inflammatory activity. The mechanism supports the broader gut comfort positioning — bloating and discomfort have inflammatory components alongside mechanical factors. Differentiates KWD+ from pure enzyme supplements (bromelain, papain) that lack the antioxidant/anti-inflammatory bioactive class.

Side effects and drug interactions

Common Potential side effects

Well-tolerated; kiwi is a common dietary fruit with long history of safe consumption.
Kiwi allergy is documented — particularly oral allergy syndrome (cross-reactive with latex or birch pollen). Those with known kiwi allergy should avoid KWD+.
Mild GI effects rare at clinical doses.
Doping-free certified — suitable for competitive athletes; kosher and halal certifications available.
Possible mild blood-thinning effect via salicylate content; minor concern but worth noting before surgery.
Pregnancy and lactation: kiwi consumption is safe in pregnancy; supplemental doses not specifically studied.
Children: not specifically tested at supplemental doses; whole kiwi is a common pediatric food.

Important Drug interactions

Kiwi allergy — known cross-reactivity with latex, birch pollen, and avocado/banana allergies; avoid if any of these allergies present.
Anticoagulants (warfarin, DOACs) — kiwi contains vitamin K and salicylates; mild theoretical interaction; monitor INR with warfarin.
Protein supplements and whey protein — KWD+ enhances digestion of these; no negative interaction expected; in fact intended synergy.
MAOIs — kiwi has trace tyramine; minimal clinical concern at KWD+ dose but worth noting.
Beta-blockers — possible mild blood pressure effects; minimal concern at supplemental doses.
Pregnancy and lactation: consult clinician for supplemental use.

Frequently asked questions about KWD+® (Kiwi Fruit Extract for Protein Digestion — Pharmactive)

What is KWD+?

KWD+® is Pharmactive Biotech Products' high-performance kiwi fruit (Actinidia deliciosa) extract for protein digestion and gut motility support. Sourced from traditionally cultured New Zealand kiwi and manufactured in Spain. Standardized to ≥0.15% actinidin (a proteolytic enzyme that breaks down proteins) and ≥0.

What is KWD+ used for?

KWD+ is researched primarily for Gut Health. Actinidin is a cysteine protease enzyme that breaks down proteins in the stomach and small intestine, converting them into more digestible peptides. KWD+ contains ~5× the actinidin concentration of fresh kiwi.

What is the recommended dosage of KWD+?

The clinically studied dose is 300 mg/day for maintenance; 600 mg before a heavy meal. Always follow the product label and check with a healthcare provider for personal advice.

Is KWD+ safe, and does it have side effects?

For most healthy adults, KWD+ is well tolerated at studied doses. Reported effects can include: Well-tolerated; kiwi is a common dietary fruit with long history of safe consumption. Kiwi allergy is documented — particularly oral allergy syndrome (cross-reactive with latex or birch pollen). Those with known kiwi allergy should avoid KWD+. It may also interact with some medications. KWD+ is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does KWD+ interact with any medications?

Possible interactions include: Kiwi allergy — known cross-reactivity with latex, birch pollen, and avocado/banana allergies; avoid if any of these allergies present. Anticoagulants (warfarin, DOACs) — kiwi contains vitamin K and salicylates; mild theoretical interaction; monitor INR with warfarin. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for KWD+?

NutraSmarts rates the evidence for KWD+ as Moderate (3 out of 5). It is backed by 3 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Park S, Church DD, Starck C, Schutzler SE, Azhar G, Kim IY, Ferrando AA, Moughan PJ, Wolfe RR The impact of Hayward green kiwifruit on dietary protein digestion and protein metabolism European Journal of Nutrition. 2021;60(2):1141-1148. doi: 10.1007/s00394-020-02363-5.PubMedUsed to support: Human RCT (n=12 older adults, double-blind crossover) showing green kiwifruit containing actinidin produced significantly faster plasma essential amino acid appearance after protein intake than gold kiwifruit lacking actinidin; supports protein digestion enhancement via actinidin and elderly digestion support claims. Evidence on whole kiwifruit (not KWD+® brand-specific) — compound-class human evidence.
  2. Wilkinson-Smith V, Dellschaft N, Ansell J, Hoad C, Marciani L, Gowland P, Spiller R Mechanisms underlying effects of kiwifruit on intestinal function shown by MRI in healthy volunteers Alimentary Pharmacology & Therapeutics. 2019;49(6):759-768. doi: 10.1111/apt.15127.PubMedUsed to support: Human RCT using MRI in healthy volunteers demonstrating kiwifruit increases small bowel water retention and ascending colon volume, increases stool frequency and softness; supports gentle gastrointestinal motility claim. Compound-class human evidence.
  3. Zhu X, Kaur L, Staincliffe M, Boland M Actinidin pretreatment and sous vide cooking of beef brisket: Effects on meat microstructure, texture and in vitro protein digestibility Meat Science. 2018;145:256-265. doi: 10.1016/j.meatsci.2018.06.029.PubMedUsed to support: In vitro and food science study showing actinidin (kiwifruit cysteine protease) pretreatment significantly enhanced initial rate of muscle protein breakdown under simulated gastric conditions and improved tenderness; supports protein digestion enhancement via actinidin mechanism claim. In vitro/food science evidence — mechanism study.
  4. Montoya CA, Cabrera DL, Zou M, Boland MJ, Moughan PJ The Rate at Which Digested Protein Enters the Small Intestine Modulates the Rate of Amino Acid Digestibility throughout the Small Intestine of Growing Pigs The Journal of Nutrition. 2018;148(11):1743-1750. doi: 10.1093/jn/nxy193.PubMedUsed to support: Animal study (growing pigs) with actinidin demonstrating that the rate of digested protein entering the small intestine directly modulates amino acid digestibility and absorption; provides mechanistic basis for actinidin’s protein digestion enhancement and vegetarian/vegan protein utilization claims. Animal/mechanistic evidence.